Nachrichten zur Navamedic ASA Aktie

Oslo, 12 February 2025 – For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…

Oslo, 4 February 2025: Board member Kathrine Elisabeth Gamborg Andreassen has informed the board of directors of Observe Medical ASA…

Oslo, 17 December 2024 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker…

Oslo, 5 December 2024: Reference is made to the stock announcement published by Observe Medical ASA (the "Observe Medical") on…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN,…

Oslo, 15 November 2024: Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on…

Oslo, November 6, 2024: Lars Hjarrand, CFO and a primary insider of Navamedic ASA, has today bought 20.000 Navamedic ASA…

Oslo, 6 November 2024 – Building on the successful product launch of Eroxon[®] in Norway and Sweden earlier this year,…

Oslo, 9 September 2024: The board of directors of Navamedic ASA (the "Company"), has today, on 9 September 2024, in…

Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…

The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Tuesday, June 4th 2024 at 09:00 (CET)…

Oslo, 30 April 30 2024 -  Navamedic ASA has today published its Annual Report for 2023 approved by the Board…

Oslo, 30 April 2024 – In the first quarter 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…

Oslo, 15 March 2024: The board of directors of Navamedic ASA (the "Company"), has today, on 15 March 2024, in…

Oslo, 12 March 2024 - Ingerø Reiten Investment Company AS ("IRIC") has today sold all of its shares in the…